Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2753 results

Sort By:

Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures

Study ID: NCT06579989
Start Date: 2026-01
End Date: 2028-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Ultrasound for cough

Ultrasound for vocal fold atrophy or vocal fold paresis/paralysis

Ultrasound for dysphagia

Ultrasound for dysphonia

Sponsor

Weill Medical College of Cornell University

Source: clinicaltrials.gov

Share:
Add to list

Low Intensity Focused Ultrasound for Parkinson's Disease

Study ID: NCT06763692
Start Date: 2025-12-01
End Date: 2028-03-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

15

Intervention / Treatment

LIFU Neuromodulation

Sponsor

Ali Rezai

Source: clinicaltrials.gov

Share:
Add to list

Assessing Spinal Accessory Nerve Recovery After Post-operative Electrical Stimulation

Study ID: NCT07074392
Start Date: 2026-01-01
End Date: 2027-03-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

38

Intervention / Treatment

Electrical Stimulation

Sponsor

McMaster University

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers

Study ID: NCT07103278
Start Date: 2025-12
End Date: 2026-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

44

Intervention / Treatment

AD-116

AD-1161

Sponsor

Addpharma Inc.

Source: clinicaltrials.gov

Share:
Add to list

Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway

Study ID: NCT07175376
Start Date: 2026-01
End Date: 2027-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

32

Intervention / Treatment

Supportive Care

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis

Study ID: NCT06016517
Start Date: 2025-11-15
End Date: 2028-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

18

Intervention / Treatment

Etanercept

Adalimumab

Upadacitinib

Tocilizumab

Sponsor

Tufts Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Study ID: NCT06931340
Start Date: 2025-11-08
End Date: 2039-05-08
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1260

Intervention / Treatment

Androgen Therapy

Apalutami

Docetaxel

Computed Tomography

Magnetic Resonance Imaging

Bone Scan

PSMA PET Scan

Biospecimen Collection

Administration Questionnaire

Sponsor

Alliance for Clinical Trials in Oncology

Source: clinicaltrials.gov

Share:
Add to list

Efficacy of Artificial Intelligence for Gatekeeping in Referrals to Specialized Care

Study ID: NCT07019116
Start Date: 2025-12-15
End Date: 2029-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

934

Intervention / Treatment

Standard gatekeeping

AI algorithm

Subsequent interactions between primary care and regulation system

Sponsor

Porto Alegre Clinical Hospital

Source: clinicaltrials.gov

Share:
Add to list

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Study ID: NCT07213778
Start Date: 2025-12-05
End Date: 2027-07-16
Study Type

Interventional

Study Phase

Phase3

No. of Participants

2000

Intervention / Treatment

REGN7508

Acetylsalicylic Acid (ASA)

Placebo

Sponsor

Regeneron Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Study ID: NCT07221149
Start Date: 2026-03-09
End Date: 2032-09-11
Study Type

Interventional

Study Phase

Phase3

No. of Participants

690

Intervention / Treatment

Cool down

Folfox

Capox

Nivolumab

Sponsor

Bristol-Myers Squibb

Source: clinicaltrials.gov

Share:
Add to list